Table of Content 1 Industry Overview 1.1 Cancer Monoclonal Antibodies Industry Figure Cancer Monoclonal Antibodies Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Cancer Monoclonal Antibodies 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Cancer Monoclonal Antibodies 1.2.2 Downstream Table Application Segment of Cancer Monoclonal Antibodies Table Global Cancer Monoclonal Antibodies Market 2015-2025, by Application, in USD Million 1.3 Cost Analysis 2 Industry Environment (PEST Analysis) 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Cancer Monoclonal Antibodies Market by Type 3.1 By Type 3.1.1 Naked mAbs Table Major Company List of Naked mAbs 3.1.2 Conjugated mAbs Table Major Company List of Conjugated mAbs 3.2 Market Size Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Type, in USD Million Figure Global Cancer Monoclonal Antibodies Market Growth 2015-2019, by Type, in USD Million Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Type, in Volume Figure Global Cancer Monoclonal Antibodies Market Growth 2015-2019, by Type, in Volume 3.3 Market Forecast Table Global Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Type, in USD Million Table Global Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Type, in Volume 4 Major Companies List 4.1 F. Hoffmann-La Roche (Company Profile, Sales Data etc.) 4.1.1 F. Hoffmann-La Roche Profile Table F. Hoffmann-La Roche Overview List 4.1.2 F. Hoffmann-La Roche Products & Services 4.1.3 F. Hoffmann-La Roche Business Operation Conditions Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.2 Amgen (Company Profile, Sales Data etc.) 4.2.1 Amgen Profile Table Amgen Overview List 4.2.2 Amgen Products & Services 4.2.3 Amgen Business Operation Conditions Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.) 4.3.1 Bristol-Myers Squibb Profile Table Bristol-Myers Squibb Overview List 4.3.2 Bristol-Myers Squibb Products & Services 4.3.3 Bristol-Myers Squibb Business Operation Conditions Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.4 Takeda Pharmaceuticals (Company Profile, Sales Data etc.) 4.4.1 Takeda Pharmaceuticals Profile Table Takeda Pharmaceuticals Overview List 4.4.2 Takeda Pharmaceuticals Products & Services 4.4.3 Takeda Pharmaceuticals Business Operation Conditions Table Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.5 Pfizer (Company Profile, Sales Data etc.) 4.5.1 Pfizer Profile Table Pfizer Overview List 4.5.2 Pfizer Products & Services 4.5.3 Pfizer Business Operation Conditions Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.6 Merck (Company Profile, Sales Data etc.) 4.6.1 Merck Profile Table Merck Overview List 4.6.2 Merck Products & Services 4.6.3 Merck Business Operation Conditions Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.7 Eli Lilly (Company Profile, Sales Data etc.) 4.7.1 Eli Lilly Profile Table Eli Lilly Overview List 4.7.2 Eli Lilly Products & Services 4.7.3 Eli Lilly Business Operation Conditions Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.8 Sanofi (Company Profile, Sales Data etc.) 4.8.1 Sanofi Profile Table Sanofi Overview List 4.8.2 Sanofi Products & Services 4.8.3 Sanofi Business Operation Conditions Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.9 Janssen Biotech (Company Profile, Sales Data etc.) 4.9.1 Janssen Biotech Profile Table Janssen Biotech Overview List 4.9.2 Janssen Biotech Products & Services 4.9.3 Janssen Biotech Business Operation Conditions Table Business Operation of Janssen Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.10 Novartis (Company Profile, Sales Data etc.) 4.10.1 Novartis Profile Table Novartis Overview List 4.10.2 Novartis Products & Services 4.10.3 Novartis Business Operation Conditions Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.11 AbbVie (Company Profile, Sales Data etc.) 4.11.1 AbbVie Profile Table AbbVie Overview List 4.11.2 AbbVie Products & Services 4.11.3 AbbVie Business Operation Conditions Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.12 Boehringer Ingelheim (Company Profile, Sales Data etc.) 4.12.1 Boehringer Ingelheim Profile Table Boehringer Ingelheim Overview List 4.12.2 Boehringer Ingelheim Products & Services 4.12.3 Boehringer Ingelheim Business Operation Conditions Table Business Operation of Boehringer Ingelheim (Sales Revenue, Cost, Gross Margin) 4.13 AstraZeneca (Company Profile, Sales Data etc.) 4.13.1 AstraZeneca Profile Table AstraZeneca Overview List 4.13.2 AstraZeneca Products & Services 4.13.3 AstraZeneca Business Operation Conditions Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.14 Bayer (Company Profile, Sales Data etc.) 4.14.1 Bayer Profile Table Bayer Overview List 4.14.2 Bayer Products & Services 4.14.3 Bayer Business Operation Conditions Table Business Operation of Bayer (Sales Revenue, Cost, Gross Margin) 4.15 Biogen (Company Profile, Sales Data etc.) 4.15.1 Biogen Profile Table Biogen Overview List 4.15.2 Biogen Products & Services 4.15.3 Biogen Business Operation Conditions Table Business Operation of Biogen (Sales Revenue, Cost, Gross Margin) 4.16 TG Therapeutics (Company Profile, Sales Data etc.) 4.16.1 TG Therapeutics Profile Table TG Therapeutics Overview List 4.16.2 TG Therapeutics Products & Services 4.16.3 TG Therapeutics Business Operation Conditions Table Business Operation of TG Therapeutics (Sales Revenue, Cost, Gross Margin) 4.17 CTI BioPharma (Company Profile, Sales Data etc.) 4.17.1 CTI BioPharma Profile Table CTI BioPharma Overview List 4.17.2 CTI BioPharma Products & Services 4.17.3 CTI BioPharma Business Operation Conditions Table Business Operation of CTI BioPharma (Sales Revenue, Cost, Gross Margin) 4.18 Intas Pharmaceuticals (Company Profile, Sales Data etc.) 4.18.1 Intas Pharmaceuticals Profile Table Intas Pharmaceuticals Overview List 4.18.2 Intas Pharmaceuticals Products & Services 4.18.3 Intas Pharmaceuticals Business Operation Conditions Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin) 4.19 Kyowa Hakko Kirin (Company Profile, Sales Data etc.) 4.19.1 Kyowa Hakko Kirin Profile Table Kyowa Hakko Kirin Overview List 4.19.2 Kyowa Hakko Kirin Products & Services 4.19.3 Kyowa Hakko Kirin Business Operation Conditions Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin) 5 Market Competition 5.1 Company Competition Table Global Cancer Monoclonal Antibodies Sales Revenue 2015-2019, by Company, in USD Million Table Global Cancer Monoclonal Antibodies Sales Revenue Share 2015-2019, by Company, in USD Million Figure Global Cancer Monoclonal Antibodies Sales Revenue Share in 2019, by Company, in USD Million Table Global Cancer Monoclonal Antibodies Sales Volume 2015-2019, by Company, in Volume Table Global Cancer Monoclonal Antibodies Sales Volume Share 2015-2019, by Company, in Volume Figure Global Cancer Monoclonal Antibodies Sales Volume Share in 2019, by Company, in Volume 5.2 Regional Market by Company Figure North America Cancer Monoclonal Antibodies Market Concentration, in 2019 Figure Europe Cancer Monoclonal Antibodies Market Market Concentration, in 2019 Figure Asia-Pacific Cancer Monoclonal Antibodies MMarket Concentration, in 2019 Figure South America Cancer Monoclonal Antibodies Market Concentration, in 2019 Figure Middle East & Africa Cancer Monoclonal Antibodies Market Concentration, in 2019 6 Demand by End Market 6.1 Demand Situation 6.1.1 Demand in Hospitals Figure Cancer Monoclonal Antibodies Demand in Hospitals, 2015-2019, in USD Million Figure Cancer Monoclonal Antibodies Demand in Hospitals, 2015-2019, in Volume 6.1.2 Demand in Retail Pharmacies Figure Cancer Monoclonal Antibodies Demand in Retail Pharmacies, 2015-2019, in USD Million Figure Cancer Monoclonal Antibodies Demand in Retail Pharmacies, 2015-2019, in Volume 6.2 Regional Demand Comparison Table Regional Demand Comparison List Table Major Application in Different Regions 6.3 Demand Forecast Table Cancer Monoclonal Antibodies Demand Forecast 2020-2025, by Application, in USD Million Figure Cancer Monoclonal Antibodies Market Growth 2020-2025, by Application, in USD Million Figure Cancer Monoclonal Antibodies Market Share in 2025, by Application, in USD Million Table Cancer Monoclonal Antibodies Demand Forecast 2020-2025, by Application, in Volume Table Cancer Monoclonal Antibodies Market Growth 2020-2025, by Application, in Volume Table Cancer Monoclonal Antibodies Market Share in 2025, by Application, in Volume 7 Region Operation 7.1 Regional Production Table Cancer Monoclonal Antibodies Production 2015-2019, by Region, in USD Million Table Cancer Monoclonal Antibodies Production 2015-2019, by Region, in Volume 7.2 Regional Market Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Region, in USD Million Table Global Cancer Monoclonal Antibodies Market Share 2015-2019, by Region, in USD Million Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Region, in Volume Table Global Cancer Monoclonal Antibodies Market Share 2015-2019, by Region, in Volume 7.3 by Region 7.3.1 North America 7.3.1.1 Overview Figure North America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure North America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume 7.3.1.2 by Country (U.S., Canada, Mexico) Table North America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table North America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume 7.3.2 Europe 7.3.2.1 Overview Figure Europe Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure Europe Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) Table Europe Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table Europe Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume 7.3.3 Asia-Pacific 7.3.3.1 Overview Figure Asia-Pacific Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure Asia-Pacific Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) Table Asia-Pacific Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table Asia-Pacific Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume 7.3.4 South America 7.3.4.1 Overview Figure South America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure South America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume 7.3.4.2 by Country (Brazil, Argentina etc.) Table South America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table South America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume 7.3.5 Middle East & Africa 7.3.5.1 Overview Figure Middle East & Africa Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure Middle East & Africa Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) Table Middle East & Africa Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table Middle East & Africa Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume 7.4 Regional Import & Export 7.5 Regional Forecast Table Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Region, in USD Million Table Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Region, in Volume 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change Table Price Factors List 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel Figure Marketing Channels Overview 9 Research Conclusion

List of Table List of Table Table Upstream Segment of Cancer Monoclonal Antibodies Table Application Segment of Cancer Monoclonal Antibodies Table Global Cancer Monoclonal Antibodies Market 2015-2025, by Application, in USD Million Table Major Company List of Conjugated mAbs Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Type, in USD Million Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Type, in Volume Table Global Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Type, in USD Million Table Global Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Type, in Volume Table F. Hoffmann-La Roche Overview List Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Amgen Overview List Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bristol-Myers Squibb Overview List Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Takeda Pharmaceuticals Overview List Table Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Pfizer Overview List Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Merck Overview List Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Eli Lilly Overview List Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sanofi Overview List Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Janssen Biotech Overview List Table Business Operation of Janssen Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novartis Overview List Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table AbbVie Overview List Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Boehringer Ingelheim Overview List Table Business Operation of Boehringer Ingelheim (Sales Revenue, Cost, Gross Margin) Table AstraZeneca Overview List Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bayer Overview List Table Business Operation of Bayer (Sales Revenue, Cost, Gross Margin) Table Biogen Overview List Table Business Operation of Biogen (Sales Revenue, Cost, Gross Margin) Table TG Therapeutics Overview List Table Business Operation of TG Therapeutics (Sales Revenue, Cost, Gross Margin) Table CTI BioPharma Overview List Table Business Operation of CTI BioPharma (Sales Revenue, Cost, Gross Margin) Table Intas Pharmaceuticals Overview List Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin) Table Kyowa Hakko Kirin Overview List Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin) Table Global Cancer Monoclonal Antibodies Sales Revenue 2015-2019, by Company, in USD Million Table Global Cancer Monoclonal Antibodies Sales Revenue Share 2015-2019, by Company, in USD Million Table Global Cancer Monoclonal Antibodies Sales Volume 2015-2019, by Company, in Volume Table Global Cancer Monoclonal Antibodies Sales Volume Share 2015-2019, by Company, in Volume Table Regional Demand Comparison List Table Major Application in Different Regions Table Cancer Monoclonal Antibodies Demand Forecast 2020-2025, by Application, in USD Million Table Cancer Monoclonal Antibodies Demand Forecast 2020-2025, by Application, in Volume Table Cancer Monoclonal Antibodies Market Growth 2020-2025, by Application, in Volume Table Cancer Monoclonal Antibodies Market Share in 2025, by Application, in Volume Table Cancer Monoclonal Antibodies Production 2015-2019, by Region, in USD Million Table Cancer Monoclonal Antibodies Production 2015-2019, by Region, in Volume Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Region, in USD Million Table Global Cancer Monoclonal Antibodies Market Share 2015-2019, by Region, in USD Million Table Global Cancer Monoclonal Antibodies Market 2015-2019, by Region, in Volume Table Global Cancer Monoclonal Antibodies Market Share 2015-2019, by Region, in Volume Table North America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table North America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume Table Europe Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table Europe Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume Table Asia-Pacific Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table Asia-Pacific Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume Table South America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table South America Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume Table Middle East & Africa Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in USD Million Table Middle East & Africa Cancer Monoclonal Antibodies Market Size 2015-2019, by Country, in Volume Table Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Region, in USD Million Table Cancer Monoclonal Antibodies Market Forecast 2020-2025, by Region, in Volume Table Price Factors ListList of Figure Figure Cancer Monoclonal Antibodies Industry Chain Structure Figure Global Cancer Monoclonal Antibodies Market Growth 2015-2019, by Type, in USD Million Figure Global Cancer Monoclonal Antibodies Market Growth 2015-2019, by Type, in Volume Figure Global Cancer Monoclonal Antibodies Sales Revenue Share in 2019, by Company, in USD Million Figure Global Cancer Monoclonal Antibodies Sales Volume Share in 2019, by Company, in Volume Figure North America Cancer Monoclonal Antibodies Market Concentration, in 2019 Figure Europe Cancer Monoclonal Antibodies Market Market Concentration, in 2019 Figure Asia-Pacific Cancer Monoclonal Antibodies MMarket Concentration, in 2019 Figure South America Cancer Monoclonal Antibodies Market Concentration, in 2019 Figure Middle East & Africa Cancer Monoclonal Antibodies Market Concentration, in 2019 Figure Cancer Monoclonal Antibodies Demand in Hospitals, 2015-2019, in USD Million Figure Cancer Monoclonal Antibodies Demand in Hospitals, 2015-2019, in Volume Figure Cancer Monoclonal Antibodies Demand in Retail Pharmacies, 2015-2019, in USD Million Figure Cancer Monoclonal Antibodies Demand in Retail Pharmacies, 2015-2019, in Volume Figure Cancer Monoclonal Antibodies Market Growth 2020-2025, by Application, in USD Million Figure Cancer Monoclonal Antibodies Market Share in 2025, by Application, in USD Million Figure North America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure North America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume Figure Europe Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure Europe Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume Figure Asia-Pacific Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure Asia-Pacific Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume Figure South America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure South America Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume Figure Middle East & Africa Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in USD Million Figure Middle East & Africa Cancer Monoclonal Antibodies Market Size and Growth 2015-2019, in Volume Figure Marketing Channels Overview